Items where Author is "Shahsavarani, Hosein"

Mirzaei, Yousef and Hussein Mer, Ali and fattah Maran, Bahia and Omidvar, Leila and Misamogooe, Fatemeh and Amirkhani, Zahra and Javaheri Haghighi, Nafiseh and Bagheri, Nader and Keshtkaran, Zahra and Rezaei, Behzad and Bargrizaneh, Farshad and Jahandideh, Saeed and Barpour, Nesa and Shahsavarani, Hosein and Bazyari, Ahmadreza and Abdollahpour‐Alitappeh, Meghdad (2024) Clinical And Preclinical Advances In PSMA-Directed Antibody-Drug Conjugates (Adcs): Current Status and Hope for The Future. Bioorganic Chemistry, 153: 107803. ISSN 00452068

Khosravanian, Mohammad Javad and Mirzaei, Yousef and Mer, Ali Hussein and Keyhani-Khankahdani, Maryam and Abdinia, Fatemeh Sarina and Misamogooe, Fatemeh and Amirkhani, Zahra and Bagheri, Nader and Meyfour, Anna and Jahandideh, Saeed and Barpour, Nesa and Nikmanesh, Yousef and Shahsavarani, Hosein and Abdollahpour-Alitappeh, Meghdad (2024) Nectin-4-directed Antibody-drug Conjugates (ADCs): Spotlight on Preclinical and Clinical Evidence. Life Sciences, 352. p. 122910. ISSN 00243205

Najminejad, Zohreh and Dehghani, Fatemeh and Mirzaei, Yousef and Hussein Mer, Ali and Amirreza Saghi, Seyyed and Haji Abdolvahab, Mohadeseh and Bagheri, Nader and Meyfour, Anna and Jafari, Ameneh and Jahandideh, Saeed and Gharibi, Tohid and Amirkhani, Zahra and Delam, Hamed and Mashatan, Noushin and Shahsavarani, Hosein and Abdollahpour-Alitappeh, Meghdad (2023) Clinical Perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer. Molecular Therapy, 31 (7). 1874 -1903. ISSN 1525-0024 (online)

Najminejad, Zohreh and Dehghani, Fatemeh and Mirzaei, Yousef and Mer, Ali Hussein and Saghi, Seyyed Amirreza and Abdolvahab, Mohadeseh Haji and Bagheri, Nader and Meyfour, Anna and Jafari, Ameneh and Jahandideh, Saeed and Gharibi, Tohid and Amirkhani, Zahra and Delam, Hamed and Mashatan, Noushin and Shahsavarani, Hosein and Abdollahpour-Alitappeh, Meghdad (2023) Exploring Antibody-Drug Conjugates in HER2-Positive Breast Cancer: Advancements and Clinical Perspectives. Molecular Therapy, 31 (7). pp. 1874-1903. ISSN 15250016